In COVID-19 clinical update #107, Daniel Griffin reviews vaccine booster doses, at-home testing, transmission in ferrets, improving indoor air quality, trials of BCG, ivermectin, and fluvoxamine, vaccination during pregnancy, mRNA vaccines and Fc functions, anti-platelet and aspirin therapy and a trial of prone positioning.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode * FDA authorizes second booster (FDA) * Second booster and mortality (Res Square) * Booster effectiveness vs hospitalization (MMWR) * SARS-CoV-2 confections (Lancet) * At-home testing (MMWR) * Transmission study in ferrets (PLoS Path) * Improving indoor air quality (EPA) * BCG vaccine no effect on viral infections (Clin Inf Dis) * Vaccination during pregnancy (JAMA) * mRNA vaccines and different Fc functions (Sci Transl Med) * Ivermectin clinical trial (NEJM) * Fluvoxamine clinical trial (Lancet) * Antiplatelet therapy (JAMA) * Aspirin and in-hospital mortality (JAMA) * Proning trial (Brit Med J) * Dr. Griffin's treatment guide (pdf) * Contribute to ASTMH fundraiser at PWB 41:20 * Letters read on TWiV 883 * Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv